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Background:  Ischemic myocardial injury creates a hostile microenvironment, which is characterized by hypoxia, oxidative stress, and 
inflammation. To enhance recovery by endogenous cellular contributions and repair by exogenously delivered cells, as in cell-based therapy, we 
aimed to alter the hostile myocardium using gene therapy. 
Methods:  Human endothelial progenitor cells (EPCs) were isolated and transduced to express protein kinase B (Akt) and heme-oxygenase-1 
(HO-1). Infarct conditions were simulated by adding hydrogen peroxide and tumor necrosis factor alpha in a hypoxic environment to human EPCs or 
cardiomyocytes; otherwise 5x10^5 cells were transplanted to post-myocardial infarct tissue of nude mice. 
Results:  Human EPCs transduced ex vivo with Akt and HO-1 alter their paracrine profile under stress, improving migration toward infarcted human 
cardiomyocytes and retention to extracellular matrix. Modified EPCs reduce the TNF_ burden both in vitro and in vivo, attenuating the activity of the 
inflammatory transcription factor NF-gB and promoting cell survival. Akt and HO-1 act synergistically to enhance EPC neovascularization, resulting in 
improved cardiac performance and reduced negative remodeling after myocardial infarction. 
Conclusions:  Paracrine alteration of the hostile infarct microenvironment through gene modification of human EPCs enhances the function and 
retention of transplanted cells for restoration of cardiac function.
